Gene
|
Entrez ID
Entrez Gene ID - the GENE ID in NCBI Gene database.
|
1050 |
Gene nameGene Name - the full gene name approved by the HGNC.
|
CCAAT enhancer binding protein alpha |
Gene symbolGene Symbol - the official gene symbol approved by the HGNC, which is a short abbreviated form of the gene name.
|
CEBPA |
SynonymsGene synonyms aliases
|
C/EBP-alpha, CEBP |
ChromosomeChromosome number
|
19 |
Chromosome locationChromosomal Location - indicates the cytogenetic location of the gene or region on the chromosome.
|
19q13.11 |
SummarySummary of gene provided in NCBI Entrez Gene.
|
This intronless gene encodes a transcription factor that contains a basic leucine zipper (bZIP) domain and recognizes the CCAAT motif in the promoters of target genes. The encoded protein functions in homodimers and also heterodimers with CCAAT/enhancer-binding proteins beta and gamma. Activity of this protein can modulate the expression of genes involved in cell cycle regulation as well as in body weight homeostasis. Mutation of this gene is associated with acute myeloid leukemia. The use of alternative in-frame non-AUG (GUG) and AUG start codons results in protein isoforms with different lengths. Differential translation initiation is mediated by an out-of-frame, upstream open reading frame which is located between the GUG and the first AUG start codons. [provided by RefSeq, Dec 2013] |
miRNAmiRNA information provided by mirtarbase database.
|
|
Transcription factors
|
|
Gene ontology (GO)Gene ontology information of associated ontologies with gene provided by GO database.
|
GO ID |
Ontology |
Definition |
Evidence |
Reference |
GO:0000050 |
Process |
Urea cycle |
IEA |
|
GO:0000122 |
Process |
Negative regulation of transcription by RNA polymerase II |
IEA |
|
GO:0000785 |
Component |
Chromatin |
ISA |
|
GO:0000976 |
Function |
Transcription regulatory region sequence-specific DNA binding |
IDA |
12695546, 28186500 |
GO:0000978 |
Function |
RNA polymerase II cis-regulatory region sequence-specific DNA binding |
IBA |
21873635 |
GO:0000981 |
Function |
DNA-binding transcription factor activity, RNA polymerase II-specific |
IBA |
21873635 |
GO:0000981 |
Function |
DNA-binding transcription factor activity, RNA polymerase II-specific |
ISA |
|
GO:0001228 |
Function |
DNA-binding transcription activator activity, RNA polymerase II-specific |
IMP |
16946298 |
GO:0001228 |
Function |
DNA-binding transcription activator activity, RNA polymerase II-specific |
ISS |
|
GO:0001889 |
Process |
Liver development |
ISS |
|
GO:0001892 |
Process |
Embryonic placenta development |
IEA |
|
GO:0003677 |
Function |
DNA binding |
TAS |
8643605 |
GO:0003682 |
Function |
Chromatin binding |
IEA |
|
GO:0003700 |
Function |
DNA-binding transcription factor activity |
IDA |
11242107, 12695546, 15664994 |
GO:0005515 |
Function |
Protein binding |
IPI |
12692227, 15107404, 16490787, 19059241, 20102225, 23814099 |
GO:0005634 |
Component |
Nucleus |
IDA |
11242107 |
GO:0005654 |
Component |
Nucleoplasm |
IDA |
|
GO:0005667 |
Component |
Transcription regulator complex |
IDA |
24429361 |
GO:0005730 |
Component |
Nucleolus |
IEA |
|
GO:0006091 |
Process |
Generation of precursor metabolites and energy |
TAS |
8643605 |
GO:0006355 |
Process |
Regulation of transcription, DNA-templated |
IDA |
15664994 |
GO:0006357 |
Process |
Regulation of transcription by RNA polymerase II |
IBA |
21873635 |
GO:0007005 |
Process |
Mitochondrion organization |
IEA |
|
GO:0007219 |
Process |
Notch signaling pathway |
IEA |
|
GO:0008134 |
Function |
Transcription factor binding |
IPI |
15664994, 24429361 |
GO:0008203 |
Process |
Cholesterol metabolic process |
IEA |
|
GO:0008285 |
Process |
Negative regulation of cell population proliferation |
IDA |
14660596 |
GO:0008285 |
Process |
Negative regulation of cell population proliferation |
ISS |
|
GO:0016032 |
Process |
Viral process |
IEA |
|
GO:0019221 |
Process |
Cytokine-mediated signaling pathway |
NAS |
15664994 |
GO:0019900 |
Function |
Kinase binding |
IPI |
15107404 |
GO:0030099 |
Process |
Myeloid cell differentiation |
IBA |
21873635 |
GO:0030099 |
Process |
Myeloid cell differentiation |
NAS |
15664994 |
GO:0030225 |
Process |
Macrophage differentiation |
IEA |
|
GO:0030324 |
Process |
Lung development |
ISS |
|
GO:0030851 |
Process |
Granulocyte differentiation |
ISS |
|
GO:0032436 |
Process |
Positive regulation of proteasomal ubiquitin-dependent protein catabolic process |
TAS |
14685163 |
GO:0042593 |
Process |
Glucose homeostasis |
ISS |
|
GO:0042803 |
Function |
Protein homodimerization activity |
ISS |
|
GO:0043032 |
Process |
Positive regulation of macrophage activation |
ISS |
|
GO:0043231 |
Component |
Intracellular membrane-bounded organelle |
IDA |
|
GO:0045444 |
Process |
Fat cell differentiation |
ISS |
|
GO:0045600 |
Process |
Positive regulation of fat cell differentiation |
IEA |
|
GO:0045669 |
Process |
Positive regulation of osteoblast differentiation |
IEA |
|
GO:0045736 |
Process |
Negative regulation of cyclin-dependent protein serine/threonine kinase activity |
TAS |
14685163 |
GO:0045892 |
Process |
Negative regulation of transcription, DNA-templated |
ISS |
|
GO:0045944 |
Process |
Positive regulation of transcription by RNA polymerase II |
IDA |
7959007, 20972335 |
GO:0045944 |
Process |
Positive regulation of transcription by RNA polymerase II |
IGI |
24429361 |
GO:0045944 |
Process |
Positive regulation of transcription by RNA polymerase II |
IMP |
16946298 |
GO:0045945 |
Process |
Positive regulation of transcription by RNA polymerase III |
IDA |
12695546 |
GO:0048469 |
Process |
Cell maturation |
IEA |
|
GO:0048839 |
Process |
Inner ear development |
IEA |
|
GO:0050729 |
Process |
Positive regulation of inflammatory response |
ISS |
|
GO:0050872 |
Process |
White fat cell differentiation |
IEA |
|
GO:0050873 |
Process |
Brown fat cell differentiation |
IEA |
|
GO:0055088 |
Process |
Lipid homeostasis |
ISS |
|
GO:0070102 |
Process |
Interleukin-6-mediated signaling pathway |
IDA |
24429361 |
GO:0071285 |
Process |
Cellular response to lithium ion |
IEA |
|
GO:0071356 |
Process |
Cellular response to tumor necrosis factor |
IEA |
|
GO:0071407 |
Process |
Cellular response to organic cyclic compound |
IEA |
|
GO:0090575 |
Component |
RNA polymerase II transcription regulator complex |
IMP |
16946298 |
|
Other IDsOther ids provides unique ids of gene in databases such as OMIM, HGNC, ENSEMBLE.
|
|
Protein
|
UniProt ID |
P49715 |
Protein name |
CCAAT/enhancer-binding protein alpha (C/EBP alpha) |
Protein function |
Transcription factor that coordinates proliferation arrest and the differentiation of myeloid progenitors, adipocytes, hepatocytes, and cells of the lung and the placenta. Binds directly to the consensus DNA sequence 5'-T[TG]NNGNAA[TG]-3' acting as an activator on distinct target genes (PubMed:11242107). During early embryogenesis, plays essential and redundant functions with CEBPB. Essential for the transition from common myeloid progenitors (CMP) to granulocyte/monocyte progenitors (GMP). Critical for the proper development of the liver and the lung (By similarity). Necessary for terminal adipocyte differentiation, is required for postnatal maintenance of systemic energy homeostasis and lipid storage (By similarity). To regulate these different processes at the proper moment and tissue, interplays with other transcription factors and modulators. Downregulates the expression of genes that maintain cells in an undifferentiated and proliferative state through E2F1 repression, which is critical for its ability to induce adipocyte and granulocyte terminal differentiation. Reciprocally E2F1 blocks adipocyte differentiation by binding to specific promoters and repressing CEBPA binding to its target gene promoters. Proliferation arrest also depends on a functional binding to SWI/SNF complex (PubMed:14660596). In liver, regulates gluconeogenesis and lipogenesis through different mechanisms. To regulate gluconeogenesis, functionally cooperates with FOXO1 binding to IRE-controlled promoters and regulating the expression of target genes such as PCK1 or G6PC1. To modulate lipogenesis, interacts and transcriptionally synergizes with SREBF1 in promoter activation of specific lipogenic target genes such as ACAS2. In adipose tissue, seems to act as FOXO1 coactivator accessing to ADIPOQ promoter through FOXO1 binding sites (By similarity). ; [Isoform 3]: Can act as dominant-negative. Binds DNA and have transctivation activity, even if much less efficiently than isoform 2. Does not inhibit cell proliferation (PubMed:14660596). ; [Isoform 4]: Directly and specifically enhances ribosomal DNA transcription interacting with RNA polymerase I-specific cofactors and inducing histone acetylation. |
PDB |
6DC0
|
Family and domains |
Pfam
Accession |
ID |
Position in sequence |
Description |
Type |
PF07716 |
bZIP_2 |
281 → 334 |
Basic region leucine zipper |
Coiled-coil |
|
Sequence |
MESADFYEAEPRPPMSSHLQSPPHAPSSAAFGFPRGAGPAQPPAPPAAPEPLGGICEHET SIDISAYIDPAAFNDEFLADLFQHSRQQEKAKAAVGPTGGGGGGDFDYPGAPAGPGGAVM PGGAHGPPPGYGCAAAGYLDGRLEPLYERVGAPALRPLVIKQEPREEDEAKQLALAGLFP YQPPPPPPPSHPHPHPPPAHLAAPHLQFQIAHCGQTTMHLQPGHPTPPPTPVPSPHPAPA LGAAGLPGPGSALKGLGAAHPDLRASGGSGAGKAKKSVDKNSNEYRVRRERNNIAVRKSR DKAKQRNVETQQKVLELTSDNDRLRKRVEQLSRELDTLRGIFRQLPESSLVKAMGNCA
|
|
Sequence length |
358 |
Interactions |
View interactions |